https://stock.noler.com/us/stock/newgen-biopharma-corp https://stock.noler.com/us/stock/newgen-biopharma-corp/accounts-notes-and-loans-receivable-net-current https://stock.noler.com/us/stock/newgen-biopharma-corp/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/newgen-biopharma-corp/accrued-liabilities-current https://stock.noler.com/us/stock/newgen-biopharma-corp/accrued-professional-fees-current https://stock.noler.com/us/stock/newgen-biopharma-corp/accumulated-depreciation https://stock.noler.com/us/stock/newgen-biopharma-corp/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/newgen-biopharma-corp/business-acquisition-percentage-of-voting-interests-acquired https://stock.noler.com/us/stock/newgen-biopharma-corp/capital-expenditures https://stock.noler.com/us/stock/newgen-biopharma-corp/cash-and-equivalents https://stock.noler.com/us/stock/newgen-biopharma-corp/cash-flow-breakdown https://stock.noler.com/us/stock/newgen-biopharma-corp/class-of-warrant-or-right-number-of-securities-called-by-each-warrant-or-right https://stock.noler.com/us/stock/newgen-biopharma-corp/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/newgen-biopharma-corp/common-stock-shares-subscribed-but-unissued https://stock.noler.com/us/stock/newgen-biopharma-corp/common-stock-value https://stock.noler.com/us/stock/newgen-biopharma-corp/common-stock-value-outstanding https://stock.noler.com/us/stock/newgen-biopharma-corp/cover-page-shares-outstanding https://stock.noler.com/us/stock/newgen-biopharma-corp/current-assets https://stock.noler.com/us/stock/newgen-biopharma-corp/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/newgen-biopharma-corp/debt-decrease-forgiveness https://stock.noler.com/us/stock/newgen-biopharma-corp/deferred-tax-assets-net https://stock.noler.com/us/stock/newgen-biopharma-corp/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/newgen-biopharma-corp/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/newgen-biopharma-corp/depreciation https://stock.noler.com/us/stock/newgen-biopharma-corp/depreciation-and-amortization https://stock.noler.com/us/stock/newgen-biopharma-corp/development-stage-enterprise-deficit-accumulated-during-development-stage https://stock.noler.com/us/stock/newgen-biopharma-corp/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/newgen-biopharma-corp/equity-issuance-per-share-amount https://stock.noler.com/us/stock/newgen-biopharma-corp/general-and-administrative-expense https://stock.noler.com/us/stock/newgen-biopharma-corp/income-tax https://stock.noler.com/us/stock/newgen-biopharma-corp/income-taxes-paid https://stock.noler.com/us/stock/newgen-biopharma-corp/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/newgen-biopharma-corp/increase-decrease-in-accrued-interest-receivable-net https://stock.noler.com/us/stock/newgen-biopharma-corp/insider-transactions-other https://stock.noler.com/us/stock/newgen-biopharma-corp/interest-paid https://stock.noler.com/us/stock/newgen-biopharma-corp/interest-paid-net https://stock.noler.com/us/stock/newgen-biopharma-corp/interest-receivable-current https://stock.noler.com/us/stock/newgen-biopharma-corp/net-cash-from-financing-activities https://stock.noler.com/us/stock/newgen-biopharma-corp/net-cash-from-investing-activities https://stock.noler.com/us/stock/newgen-biopharma-corp/net-cash-from-operating-activities https://stock.noler.com/us/stock/newgen-biopharma-corp/net-change-in-cash https://stock.noler.com/us/stock/newgen-biopharma-corp/net-income https://stock.noler.com/us/stock/newgen-biopharma-corp/notes-payable-related-parties-classified-current https://stock.noler.com/us/stock/newgen-biopharma-corp/operating-expenses https://stock.noler.com/us/stock/newgen-biopharma-corp/operating-income https://stock.noler.com/us/stock/newgen-biopharma-corp/operating-loss-carryforwards https://stock.noler.com/us/stock/newgen-biopharma-corp/other-nonoperating-expense https://stock.noler.com/us/stock/newgen-biopharma-corp/pretax-income https://stock.noler.com/us/stock/newgen-biopharma-corp/proceeds-from-notes-payable https://stock.noler.com/us/stock/newgen-biopharma-corp/proceeds-from-related-party-debt https://stock.noler.com/us/stock/newgen-biopharma-corp/proceeds-from-stock-issued https://stock.noler.com/us/stock/newgen-biopharma-corp/professional-fees https://stock.noler.com/us/stock/newgen-biopharma-corp/property-plant-and-equipment-gross https://stock.noler.com/us/stock/newgen-biopharma-corp/property-plant-equipment https://stock.noler.com/us/stock/newgen-biopharma-corp/public-float https://stock.noler.com/us/stock/newgen-biopharma-corp/retained-earnings https://stock.noler.com/us/stock/newgen-biopharma-corp/revenue https://stock.noler.com/us/stock/newgen-biopharma-corp/share-price https://stock.noler.com/us/stock/newgen-biopharma-corp/shareholders-equity https://stock.noler.com/us/stock/newgen-biopharma-corp/shares-authorized https://stock.noler.com/us/stock/newgen-biopharma-corp/shares-issued https://stock.noler.com/us/stock/newgen-biopharma-corp/shares-issued-for-acquisitions https://stock.noler.com/us/stock/newgen-biopharma-corp/shares-issued-price-per-share https://stock.noler.com/us/stock/newgen-biopharma-corp/stock-issued-new-shares-sold https://stock.noler.com/us/stock/newgen-biopharma-corp/stock-issued-shares-issued-shares-issued-for-cash https://stock.noler.com/us/stock/newgen-biopharma-corp/stock-issued-shares-issued-shares-new-issues https://stock.noler.com/us/stock/newgen-biopharma-corp/stock-issued-shares-issued-value-issued-for-cash https://stock.noler.com/us/stock/newgen-biopharma-corp/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/newgen-biopharma-corp/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/newgen-biopharma-corp/total-assets https://stock.noler.com/us/stock/newgen-biopharma-corp/total-liabilities https://stock.noler.com/us/stock/newgen-biopharma-corp/total-liabilities-and-equity https://stock.noler.com/us/stock/newgen-biopharma-corp/weighted-average-number-of-share-outstanding-basic-and-diluted